Study: Liver Cancer Breakthrough

[Swede]

The results in a multinational study of 602 patients with advanced liver cancer are impressive and likely will change the way patients are treated, say cancer specialists, including the study authors.

The study was halted early in February because of the good results, and patients on dummy pills were switched to sorafenib.

"This is a very good step forward in this disease," said Dr. Emily Chan of Vanderbilt-Ingram Cancer Center in Nashville, Tenn.

http://www.time.com/time/health/article/0,8599,1629575,00.html